Retinal ganglion cell (RGC) programmed necrosis contributes to ischemia-reperfusion-induced retinal damage

Galina Dvoriantchikova, Alexei Degterev, Dmitry V Ivanov

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Retinal ischemia-reperfusion (IR) injury remains a common cause of blindness and has a final pathway of retinal ganglion cell (RGC) death by apoptosis and necrosis. RGC apoptosis was intensively studied in IR injury, while RGC necrosis did not receive nearly enough consideration since it was viewed as an accidental and unregulated cellular event. However, there is evidence that necrosis, like apoptosis, can be implemented by a programmed mechanism. In this study, we tested the role of RGC programmed necrosis (necroptosis) in IR-induced retinal injury. We employed the mouse model of retinal IR injury for invivo experiments. The oxygen and glucose deprivation (OGD) model was used as an IR model invitro. Primary RGCs were isolated by an immunopanning technique. Necrostatin 1 (Nec1) was used to inhibit necroptosis in invitro and invivo experiments. The changes in gene expression were assessed by quantitative RT-PCR. The distribution of proteins in the retina and in RGC cultures was evaluated by immunohistochemistry and immunocytochemistry, respectively. Our data suggest that proteins (Ripk1 and Ripk3), which initiate necroptosis, were present in normal and ischemic RGCs. Treatment with Nec1 significantly reduced retinal damage after IR. Increased RGC survival and reduced RGC necrosis following OGD were observed in Nec1-treated cultures. We found significantly reduced expression of genes coding pro-inflammatory markers Il1b, Ccl5, Cxcl10, Nos2 and Cybb in Nec1-treated ischemic retinas. Thus, our findings suggest that RGC necroptosis contributes to retinal damage after IR through direct loss of cells and induction of associated inflammatory responses.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalExperimental Eye Research
Volume123
DOIs
StatePublished - Jan 1 2014

Fingerprint

Retinal Ganglion Cells
Reperfusion
Ischemia
Reperfusion Injury
Apoptosis
Retina
Immunohistochemistry
Oxygen
Gene Expression
Glucose
Blindness
Cell Survival
Proteins
Cell Death
Cell Culture Techniques
Polymerase Chain Reaction
necrostatin-1
Wounds and Injuries

Keywords

  • Ischemia-reperfusion
  • Necroptosis
  • Necrostatin 1
  • Retinal damage
  • Retinal ganglion cells
  • Ripk1
  • Ripk3

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Retinal ganglion cell (RGC) programmed necrosis contributes to ischemia-reperfusion-induced retinal damage. / Dvoriantchikova, Galina; Degterev, Alexei; Ivanov, Dmitry V.

In: Experimental Eye Research, Vol. 123, 01.01.2014, p. 1-7.

Research output: Contribution to journalArticle

@article{d3b0bfff1c104c19a2ee89b4680e9a0f,
title = "Retinal ganglion cell (RGC) programmed necrosis contributes to ischemia-reperfusion-induced retinal damage",
abstract = "Retinal ischemia-reperfusion (IR) injury remains a common cause of blindness and has a final pathway of retinal ganglion cell (RGC) death by apoptosis and necrosis. RGC apoptosis was intensively studied in IR injury, while RGC necrosis did not receive nearly enough consideration since it was viewed as an accidental and unregulated cellular event. However, there is evidence that necrosis, like apoptosis, can be implemented by a programmed mechanism. In this study, we tested the role of RGC programmed necrosis (necroptosis) in IR-induced retinal injury. We employed the mouse model of retinal IR injury for invivo experiments. The oxygen and glucose deprivation (OGD) model was used as an IR model invitro. Primary RGCs were isolated by an immunopanning technique. Necrostatin 1 (Nec1) was used to inhibit necroptosis in invitro and invivo experiments. The changes in gene expression were assessed by quantitative RT-PCR. The distribution of proteins in the retina and in RGC cultures was evaluated by immunohistochemistry and immunocytochemistry, respectively. Our data suggest that proteins (Ripk1 and Ripk3), which initiate necroptosis, were present in normal and ischemic RGCs. Treatment with Nec1 significantly reduced retinal damage after IR. Increased RGC survival and reduced RGC necrosis following OGD were observed in Nec1-treated cultures. We found significantly reduced expression of genes coding pro-inflammatory markers Il1b, Ccl5, Cxcl10, Nos2 and Cybb in Nec1-treated ischemic retinas. Thus, our findings suggest that RGC necroptosis contributes to retinal damage after IR through direct loss of cells and induction of associated inflammatory responses.",
keywords = "Ischemia-reperfusion, Necroptosis, Necrostatin 1, Retinal damage, Retinal ganglion cells, Ripk1, Ripk3",
author = "Galina Dvoriantchikova and Alexei Degterev and Ivanov, {Dmitry V}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.exer.2014.04.009",
language = "English",
volume = "123",
pages = "1--7",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Retinal ganglion cell (RGC) programmed necrosis contributes to ischemia-reperfusion-induced retinal damage

AU - Dvoriantchikova, Galina

AU - Degterev, Alexei

AU - Ivanov, Dmitry V

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Retinal ischemia-reperfusion (IR) injury remains a common cause of blindness and has a final pathway of retinal ganglion cell (RGC) death by apoptosis and necrosis. RGC apoptosis was intensively studied in IR injury, while RGC necrosis did not receive nearly enough consideration since it was viewed as an accidental and unregulated cellular event. However, there is evidence that necrosis, like apoptosis, can be implemented by a programmed mechanism. In this study, we tested the role of RGC programmed necrosis (necroptosis) in IR-induced retinal injury. We employed the mouse model of retinal IR injury for invivo experiments. The oxygen and glucose deprivation (OGD) model was used as an IR model invitro. Primary RGCs were isolated by an immunopanning technique. Necrostatin 1 (Nec1) was used to inhibit necroptosis in invitro and invivo experiments. The changes in gene expression were assessed by quantitative RT-PCR. The distribution of proteins in the retina and in RGC cultures was evaluated by immunohistochemistry and immunocytochemistry, respectively. Our data suggest that proteins (Ripk1 and Ripk3), which initiate necroptosis, were present in normal and ischemic RGCs. Treatment with Nec1 significantly reduced retinal damage after IR. Increased RGC survival and reduced RGC necrosis following OGD were observed in Nec1-treated cultures. We found significantly reduced expression of genes coding pro-inflammatory markers Il1b, Ccl5, Cxcl10, Nos2 and Cybb in Nec1-treated ischemic retinas. Thus, our findings suggest that RGC necroptosis contributes to retinal damage after IR through direct loss of cells and induction of associated inflammatory responses.

AB - Retinal ischemia-reperfusion (IR) injury remains a common cause of blindness and has a final pathway of retinal ganglion cell (RGC) death by apoptosis and necrosis. RGC apoptosis was intensively studied in IR injury, while RGC necrosis did not receive nearly enough consideration since it was viewed as an accidental and unregulated cellular event. However, there is evidence that necrosis, like apoptosis, can be implemented by a programmed mechanism. In this study, we tested the role of RGC programmed necrosis (necroptosis) in IR-induced retinal injury. We employed the mouse model of retinal IR injury for invivo experiments. The oxygen and glucose deprivation (OGD) model was used as an IR model invitro. Primary RGCs were isolated by an immunopanning technique. Necrostatin 1 (Nec1) was used to inhibit necroptosis in invitro and invivo experiments. The changes in gene expression were assessed by quantitative RT-PCR. The distribution of proteins in the retina and in RGC cultures was evaluated by immunohistochemistry and immunocytochemistry, respectively. Our data suggest that proteins (Ripk1 and Ripk3), which initiate necroptosis, were present in normal and ischemic RGCs. Treatment with Nec1 significantly reduced retinal damage after IR. Increased RGC survival and reduced RGC necrosis following OGD were observed in Nec1-treated cultures. We found significantly reduced expression of genes coding pro-inflammatory markers Il1b, Ccl5, Cxcl10, Nos2 and Cybb in Nec1-treated ischemic retinas. Thus, our findings suggest that RGC necroptosis contributes to retinal damage after IR through direct loss of cells and induction of associated inflammatory responses.

KW - Ischemia-reperfusion

KW - Necroptosis

KW - Necrostatin 1

KW - Retinal damage

KW - Retinal ganglion cells

KW - Ripk1

KW - Ripk3

UR - http://www.scopus.com/inward/record.url?scp=84899833069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899833069&partnerID=8YFLogxK

U2 - 10.1016/j.exer.2014.04.009

DO - 10.1016/j.exer.2014.04.009

M3 - Article

C2 - 24751757

AN - SCOPUS:84899833069

VL - 123

SP - 1

EP - 7

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

ER -